AI-powered search
Try Polaris, our new AI-powered search!

How does lebrikizumab impact the quality of life in patients with moderate to severe atopic dermatitis?

Featuring Raj Chovatiya, MD, PhD, MSCI |

Clinical Associate Professor, Rosalind Franklin University Chicago Medical School, Founder and Director, Center for Medical Dermatology and Immunology Research 
Chicago, IL

| Published December 02, 2024